ADAR1 Capital Management’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.14M Sell
43,935
-11,258
-20% -$334K 0.05% 173
2026
Q2
$1.74M Buy
+55,193
New +$1.25M 0.08% 146

Other funds holding CUE

ADAR1 Capital Management's CUE Position: Q3 2026 in Review

ADAR1 Capital Management reduced its Cue Biopharma (CUE) stake by 20% in Q3 2026, selling an estimated $334K and leaving 43,935 shares worth $1.14M. The position accounts for 0.05% of the portfolio, ranked #173.

ADAR1 Capital Management first reported a position in CUE in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.74M in Q2 2026. 58 funds tracked by Wall St. Rank hold CUE as of Q3 2026.

  • ADAR1 Capital Management held 43,935 shares of Cue Biopharma worth $1.14M as of Q3 2026.
  • ADAR1 Capital Management sold 11,258 Cue Biopharma shares in Q3 2026, an estimated $334K.
  • Cue Biopharma made up 0.05% of ADAR1 Capital Management's portfolio in Q3 2026, its #173 holding.
  • ADAR1 Capital Management first reported a position in Cue Biopharma in Q2 2026 and has held it in 2 quarters since.
  • ADAR1 Capital Management's Cue Biopharma position peaked at $1.74M in Q2 2026.
  • 58 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2026.

Based on ADAR1 Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.